Search

Displaying results 5291 - 5300 of 10000 in total
  1. Drug

    Lirentelimab

    go.drugbank.com/drugs/DB16728
    Investigational

    Lirentelimab is under investigation in clinical trial NCT04856891 (A Study of Lirentelimab (AK002) in Patients With Active Eosinophilic Duodenitis).

    Synonyms: IMMUNOGLOBULIN G1-KAPPA, ANTI-(HOMO SAPIENS SIALIC ACID-BINDING IG-LIKE LECTIN 8 (SIALOADHESIN FAMILY MEMBER 2, SIGLEC-8, SAF-2))HUMANIZED MOUSE MONOCLONAL ANTIBODY.GAMMA.1 HEAVY CHAIN (1-450) (VH (HOMO, Recombinant humanized, non-fucosylated IgG1 anti-Siglec-8 monoclonal antibody
  2. Drug

    Favezelimab

    go.drugbank.com/drugs/DB16729
    Investigational

    Favezelimab is under investigation in clinical trial NCT04626479 (Substudy 03A: A Study of Immune and Targeted Combination Therapies in Participants With First Line (1L) Renal Cell Carcinoma (MK-3475-03A

  3. Drug

    MK-886

    go.drugbank.com/drugs/DB16739
    Experimental

    MK-886 is an experimental inhibitor of leukotriene synthesis.

    Categories: Heterocyclic Compounds, 2-Ring
  4. Drug

    RP-67580

    go.drugbank.com/drugs/DB16742
    Experimental

    Categories: Neurokinin-1 Receptor Antagonists, Heterocyclic Compounds, 2-Ring
  5. Drug

    Cytochalasin B

    go.drugbank.com/drugs/DB16766
    Experimental

    Synonyms: Cytochalasin B, Cytochalasin-BCategories: Heterocyclic Compounds, 2-Ring
  6. Drug

    Tyrphostin B56

    go.drugbank.com/drugs/DB16775
    Experimental

    Categories: Heterocyclic Compounds, 2-Ring
  7. Drug

    AZD-5069

    go.drugbank.com/drugs/DB16822
    Investigational

    Categories: Heterocyclic Compounds, 1-Ring
  8. Drug

    AZD-7648

    go.drugbank.com/drugs/DB16834
    Investigational

    Categories: Heterocyclic Compounds, 1-Ring, Heterocyclic Compounds, 2-Ring
  9. Drug

    Pidnarulex

    go.drugbank.com/drugs/DB16846
    Investigational

    Categories: Heterocyclic Compounds, 1-Ring, Heterocyclic Compounds, 2-Ring
  10. Drug

    Olprinone

    go.drugbank.com/drugs/DB16847
    Investigational

    Categories: Heterocyclic Compounds, 1-Ring, Phosphodiesterase 3 Inhibitors